Scott Rocklage has been the managing partner of 5AM Venture Management LLC since 2004. He joined 5AM Ventures in 2003 as a Venture Partner.
He has over 30 years of experience in the management of healthcare, and he is also an expert in strategic management that has led the FDA approval of three drugs in U.S.
Scott M. Rocklage studied at the University of California where he pursued B.S in Chemistry. He pursued his PhD at MIT where he studied Chemistry and did his research in Richard R. Schrocks’ Laboratory.
He has served EPIRUS Biopharmaceutical, Inc as its CEO since July 2016 and has also served as a chairman of various boards, including Rennovia Inc.
Scott Rocklage joined 5AM Ventures investors who founded the company that used to be called Bay City Capital. After Scott joining the team, the company showed an upward trend. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift and http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY
This is because he was responsible for seeing that the drugs were approved, infrastructures, where the drugs can be launched, were built and he developed a strong pipeline.
5AM Ventures is one of the big venture capital company that is determined to build next-generation life science companies that will have a capacity of giving high returns to investors.
They support companies that are trying to solve health care problems by use of science and medicine.
5AM Ventures’ success can be attributed to the fact that it has a team of specialized professional that have strong operational, legal, scientific, medical, and financial expertise.
This helps the company to find, determine, and shape portfolio companies. 5AM Ventures also tries to help these companies in areas of management recruiting, strategy, fundraising, and business development.
Dr Rocklage has been in the forefront in the leadership of 5AM Ventures. In his position, he has assisted many companies that are attached to 5AM group by enabling to treat various diseases.
5AM’s success is greatly attributed to the leadership of Dr Rocklage. He has an excellent approach to solving scientific problems and also, he is an expert in choosing the right company to work with. He is the best asset for 5AM Venture!